Literature DB >> 20671749

Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo.

M K Lee1, W M Tong, Z Q Wang, K Sabapathy.   

Abstract

Cellular stimulation results in phosphorylation of the tumor suppressor p53 on multiple residues, though the functional relevance is not always clear. It is noteworthy that the serine (S) 315 residue is unique, as it has been suggested to be phosphorylated not only by genotoxic signals, but also during cell-cycle progression and by endoplasmic-reticulum stress. However, in vitro data have been conflicting as phosphorylation at this site was shown to both positively and negatively regulate p53 functions. We have thus generated knock-in mice expressing an unphosphorylable S312 (equivalent to human S315), by substitution with an alanine (A) residue, to clarify the conflicting observations and to evaluate its functional relevance in vivo. Born at Mendelian ratios, the p53(S312A/S312A) mice show no anomalies during development and adulthood. p53 activation, stability, localization and ability to induce apoptosis, cell-cycle arrest and prevent centrosome amplification are not compromised in p53(S312A/S312A) cells. p53(S312A/S312A) mice are unable to rescue mdm2(-/-) lethality, and tumorigenesis--both spontaneous and irradiation/oncogene-induced--is not accentuated. Taken together, the results show that the S312 phosphorylation site is not in itself necessary for efficient p53 function, and advocates the possibility that it is neither relevant in the mouse context nor important for p53 functions in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671749      PMCID: PMC3131886          DOI: 10.1038/cdd.2010.90

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription.

Authors:  J P Blaydes; M G Luciani; S Pospisilova; H M Ball; B Vojtesek; T R Hupp
Journal:  J Biol Chem       Date:  2000-11-14       Impact factor: 5.157

2.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  Regulation of p53 responses by post-translational modifications.

Authors:  Yang Xu
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

4.  Activation of p53 by roscovitine-mediated suppression of MDM2 expression.

Authors:  W Lu; L Chen; Y Peng; J Chen
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

5.  The infant mouse as a in vivo model for the detection and study of DNA damage-induced changes in the liver.

Authors:  Randall Reynolds; Sam Witherspoon; Tony Fox
Journal:  Mol Carcinog       Date:  2004-05       Impact factor: 4.784

6.  Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage.

Authors:  Michael H Brodsky; Brian T Weinert; Garson Tsang; Yikang S Rong; Nadine M McGinnis; Kent G Golic; Donald C Rio; Gerald M Rubin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  Phosphorylation of serine 18 regulates distinct p53 functions in mice.

Authors:  Hayla K Sluss; Heather Armata; Judy Gallant; Stephen N Jones
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.

Authors:  Hiroshi Katayama; Kaori Sasai; Hidehiko Kawai; Zhi-Min Yuan; Jolanta Bondaruk; Fumio Suzuki; Satoshi Fujii; Ralph B Arlinghaus; Bogdan A Czerniak; Subrata Sen
Journal:  Nat Genet       Date:  2003-12-14       Impact factor: 38.330

9.  Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta.

Authors:  LiKe Qu; Shirley Huang; Dionissios Baltzis; Ana-Maria Rivas-Estilla; Olivier Pluquet; Maria Hatzoglou; Costas Koumenis; Yoichi Taya; Akihiko Yoshimura; Antonis E Koromilas
Journal:  Genes Dev       Date:  2004-01-26       Impact factor: 11.361

Review 10.  Loss of p53 and centrosome hyperamplification.

Authors:  Pheruza Tarapore; Kenji Fukasawa
Journal:  Oncogene       Date:  2002-09-09       Impact factor: 9.867

View more
  8 in total

Review 1.  Illuminating p53 function in cancer with genetically engineered mouse models.

Authors:  Patty B Garcia; Laura D Attardi
Journal:  Semin Cell Dev Biol       Date:  2014-01-03       Impact factor: 7.727

Review 2.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

3.  Dynamics of re-constitution of the human nuclear proteome after cell division is regulated by NLS-adjacent phosphorylation.

Authors:  Gergely Róna; Máté Borsos; Jonathan J Ellis; Ahmed M Mehdi; Mary Christie; Zsuzsanna Környei; Máté Neubrandt; Judit Tóth; Zoltán Bozóky; László Buday; Emília Madarász; Mikael Bodén; Bostjan Kobe; Beáta G Vértessy
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 4.  p63 the guardian of human reproduction.

Authors:  Ivano Amelio; Francesca Grespi; Margherita Annicchiarico-Petruzzelli; Gerry Melino
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

Review 5.  Regulation of p73 activity by post-translational modifications.

Authors:  F Conforti; A E Sayan; R Sreekumar; B S Sayan
Journal:  Cell Death Dis       Date:  2012-03-15       Impact factor: 8.469

6.  Understanding p53 functions through p53 antibodies.

Authors:  Kanaga Sabapathy; David P Lane
Journal:  J Mol Cell Biol       Date:  2019-04-01       Impact factor: 6.216

Review 7.  NRF2 and p53: Januses in cancer?

Authors:  Barak Rotblat; Gerry Melino; Richard A Knight
Journal:  Oncotarget       Date:  2012-11

Review 8.  Regulating tumor suppressor genes: post-translational modifications.

Authors:  Ling Chen; Shuang Liu; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2020-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.